Evidence map›Paper›PMID 41350939›Full record

ArticleThe EMBO journal2026

O-mannosylation of misfolded ER proteins promotes ERAD.

Leticia Lemus, Hadar Meyer, Ana I Rodríguez-Rosado, Maya Schuldiner, Veit Goder

Abstract read
In one paragraph

Article in The EMBO journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Leticia LemusDepartment of Genetics, University of Seville, Seville, Spain. llemus@us.es.ORCID 0000-0001-6723-1290
Hadar MeyerDepartment of Molecular Genetics, Weizmann Institute of Sciences, Rehovot, Israel.
Ana I Rodríguez-RosadoDepartment of Genetics, University of Seville, Seville, Spain.
Maya SchuldinerDepartment of Molecular Genetics, Weizmann Institute of Sciences, Rehovot, Israel.ORCID 0000-0001-9947-115X
Veit GoderDepartment of Genetics, University of Seville, Seville, Spain. vgoder@us.es.ORCID 0000-0003-0854-4873

Funding

EC | ERC | HORIZON EUROPE European Research Council (ERC) OnTarget 864068EC | European Regional Development Fund and Junta de Andalucia USE-20487-VEMBO Scientific Exchange 11267MEC | Agencia Estatal de Investigación (AEI) PID2022-136665NB-I00
6 · The paper itself

Abstract

Protein quality control (PQC) in the secretory pathway, a process critically linked to numerous human diseases, begins in the endoplasmic reticulum (ER) and involves ER-associated degradation (ERAD) of terminally misfolded proteins. In this study, we conducted genome-wide screens in baker's yeast (Saccharomyces cerevisiae) to investigate the degradation of Gas1*, a misfolded version of an O-mannosylated, glycosylphosphatidylinositol (GPI)-anchored protein. In combination with detailed biochemical and genetic analyses, these screens revealed an unexpected bifunctionality of the evolutionarily conserved heteromeric enzyme complex Pbn1-Gpi14: while it has been previously recognized as a GPI-mannosyltransferase, we here find that it catalyzes the O-mannosylation of misfolded proteins, thereby promoting their ERAD. This process is particularly relevant for misfolded proteins that lack N-glycans. Our results suggest that protein O-mannosylation constitutes a distinct type of glycan-dependent mechanism for promoting ERAD.

Indexed as

Endoplasmic ReticulumEndoplasmic Reticulum-Associated DegradationMannoseProtein FoldingSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsGlycosylationMannosyltransferasesMannoseMannosyltransferasesSaccharomyces cerevisiae ProteinsERADER Quality ControlGpi14Pbn1Protein O-Mannosylation

Identifiers

PMID41350939
PMCPMC12811338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.